Thursday, June 5
8:00 am - 6:00 pm
Room: Pudong Shangri-La Hotel Shanghai, China
| 10:30 am |
Why Cerebral Protection after TAVR Will Become the Standard of Care
Eberhard Grube
|
| 10:30 am |
Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future
Ganesh Manoharan
|
| 10:45 am |
Stroke Basics after Cardiovascular Interventions: VARC 2 Definitions, Stroke Severity Assessment, Neuroimaging, and Neurocognitive Function
Martin Leon
|
| 10:45 am |
Perspectives from the US CoreValve Trials
Jeffrey Popma
|
| 10:45 am |
Perspectives from the PARTNER Trials
Susheel Kodali
|
| 10:45 am |
Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact
Samir Kapadia
|
| 10:45 am |
Has Stroke Frequency Declined After TAVR?
Nicolas van Mieghem
|
| 10:45 am |
A Rationale Approach to Adjunct Pharmacotherapy After TAVR (With Stroke in Mind)
Susheel Kodali
|
| 10:45 am |
A Critical Analysis of Present Data on Cerebral Protection after TAVR
Axel Linke
|